PROF
Profound Medical Corp
NASDAQ: PROF · HEALTHCARE · MEDICAL DEVICES
$7.22
-0.69% today
Updated 2026-05-06
Market cap
$262.04M
P/E ratio
—
P/S ratio
16.28x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$4 – $9
Volume
0.2M
Profound Medical Corp (PROF) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-264.40%
Operating margin
-123.30%
ROE
-67.10%
ROA
-34.90%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | — | $-8.20M | — | — | — |
| 2015 | $0.00 | $-11.80M | — | — | — |
| 2016 | $0.00 | $-12.15M | — | — | — |
| 2017 | $3.90M | $-14.97M | 38.18% | -451.94% | -383.77% |
| 2018 | $1.91M | $-15.24M | 31.66% | -776.04% | -797.88% |
| 2019 | $4.17M | $-15.22M | 57.26% | -357.07% | -364.69% |
| 2020 | $7.30M | $-21.62M | 47.56% | -258.26% | -296.03% |
| 2021 | $6.87M | $-30.70M | 42.95% | -440.72% | -446.66% |
| 2022 | $6.68M | $-28.67M | 45.22% | -480.86% | -429.11% |
| 2023 | $7.20M | $-28.57M | 60.87% | -397.50% | -396.85% |
| 2024 | $10.17M | $-26.48M | 65.89% | -309.57% | -260.45% |
| 2025 | $16.38M | $42.32M | 69.56% | -256.27% | 258.35% |